‘No change’ in risk profile with second blood clot case linked to AstraZeneca Two cases of clotting in 700,000 administered doses does not indicate an increased level of risk, experts have said.
Broader storage conditions for Pfizer vaccine bring GPs into the fold TGA-approved guideline changes have opened the possibility for general practices to take part in the rollout of the mRNA vaccine.
No legal risk for GPs administering AstraZeneca vaccine: Health Minister Greg Hunt has moved to reassure practitioners amid reports GPs stopped offering AstraZeneca to under-50s following recent ATAGI recommendations.
Changes to the vaccine rollout: What are the immediate impacts for GPs? Effects of Australia’s pivot from AstraZeneca to Pfizer for people under 50 are being felt as practices work to ease patient concerns.
ATAGI recommends major change to vaccine rollout Australian health authorities have recommended people under 50 receive the Pfizer vaccine rather than AstraZeneca.
Brendan Murphy says most GPs ‘incredibly happy’ with vaccine rollout The DoH Secretary acknowledges ‘a couple of instances’ of GPs being upset receiving fewer doses, but said supply issues are to blame.
GPs ‘in the dark’ over aged care vaccination delays Failure to reach vaccination targets and a lack of communication has left GPs concerned and unable to prepare for the influenza vaccine rollout.
mRNA COVID vaccine ‘well-tolerated’ in adolescents According to Pfizer, its vaccine is safe and effective in children as young as 12, which could be crucial for herd immunity.
Current COVID vaccines could be ineffective by next year: epidemiologists New coronavirus variants emerging in global hotspots are likely to impact vaccine efficacy. What does this mean for Australia?
GPs need ‘complete predictability on supply’: Calls for better communication amid vaccine delays Lagging deliveries have forced some GPs to be creative in securing vaccines for their patients.